Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
Clinical trial NCT04591392 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04591392
- Sponsor
- atHeart Medical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-12
- Primary completion
- 2027-03-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.